Sharepoint Solutions
PRODUCTS
-
Guide operators through dynamic workflows from equipment startup to maintenance.
-
The TWIST™ Mini Liposome Extruder System is an all-inclusive modular liposome extrusion system. The intuitive design allows novice and expert users the ability to create liposome particles ranging from 50 nm to 10 um in diameter. With the heat block and extruder base, users have extended liposome creation capabilities and an easy, ergonomic set up. The TWIST™ System is the perfect solution for small scale R&D and liposome exploration projects.
-
Start getting accurate, high-quality, and timely biostatistics services delivered by this team of biostatisticians and statistical programmers, in addition to statistical planning, analysis, and reporting.
-
Automated PUPSIT and sterile filtration with enhanced product recovery.
-
Enables secure real-time document review, co-authoring, and redaction in order to shorten the document review process by up to 65%.
WHITE PAPERS AND CASE STUDIES
-
A Top Ten CRO Deploys IDBS Polar For Faster BioPharma Development
Learn how a leading Contract Research Organization focused on bringing life-changing therapies to patients faster, chose to manage its data reporting, assay management, and equipment management.
-
Streamlining Single-Use Assemblies In The Bulk-Fill Step Of Downstream Processing
Single-use (SU) systems and components are growing in demand as they offer minimal contamination risk. Review a standardized SU assembly for bulk-fill processing that aims to improve efficiency.
-
Decentralized Trials For Duchenne Muscular Dystrophy
Partnering with a global biotech, see how MRN was able to conduct 180+ monthly home visits to sustain trials for rare disease genetic medicine in vulnerable pediatric patients during COVID-19.
-
CDMO Accelerates Contract Manufacturing With Electronic Batch Records
A prominent CDMO sought a specialized software solution to streamline and accelerate its manufacturing processes, enabling the efficient production of complex, customized products in record time.
-
The EMR Interoperability Dream Vs. Clinical Research Reality
Seamless Electronic Medical Record access promises accelerated trials and regulatory-grade evidence, but incomplete, unstructured data requires hybrid strategies using AI and human oversight to bridge gaps.
-
The Digital Transformation Of A Leading CDMO's Process Development Lab
Discover how a leading CDMO was able to create a data model for its bioreactors, resulting in easily contextualized data, time savings in manual tasks, and the ability to share insights in real time.
-
The New Industry Migration Framework For FSP
Review why a functional service provider should be on the top of a sponsor’s list when it comes to choosing a specialized eClinical data management provider for its next study.
-
Container Selection For A Highly Sensitive Drug Product: A Success Story
Learn about the importance of selecting the right container for sensitive drug products and how close collaboration is crucial for avoiding commercialization delays and safety risks to patients.
-
Biostatistics And Programming — More Than Just Clinical Trials
See how our biostatisticians and programmers successfully ingested, cleaned, and analyzed the data, ultimately providing a small biotech company with several interesting and actionable measures.
-
Small Town Realizes Big Savings With Prefabricated Lift Stations
Discover how a small town added modern automation and controls to improve operations and minimize maintenance.
-
Success Factors For Launching Products With Orphan Drug Designation
Orphan drug designation offers a number of financial incentives to pharmaceutical companies. Learn more about the potential hurdles of orphan drug development and the opportunities to maximize your success.
-
Six Strategies For Accelerating Approval For Cell And Gene Therapies
As you advance through the evolving regulatory landscape for cell and gene therapies, review these six proven strategies to help sponsors reduce their risk of failure and expedite speed to market.
NEWS
-
Biden-Harris Administration Announces $3B For Lead Pipe Replacement To Advance Safe Drinking Water As Part Of Investing In America Agenda5/2/2024
Today, May 2, the U.S. Environmental Protection Agency announced $3B from President Biden’s Investing in America agenda to help every state and territory identify and replace lead service lines, preventing exposure to lead in drinking water.
-
EPA Announces $7 Billion In Newly Available WIFIA Funding And Five New WIFIA Loan Approvals11/20/2025
The U.S. Environmental Protection Agency (EPA) has announced $6.5 billion in Water Infrastructure Finance and Innovation Act (WIFIA) funding available for water systems, with an additional $550 million available to states. Interested entities can apply for this funding through a rolling application process.
-
EPA Announces $194M To King County To Improve Wastewater Infrastructure Resiliency, Protect Puget Sound3/28/2024
Today, at an event at the West Point Treatment Plant, the U.S. Environmental Protection Agency Acting Assistant Administrator for Water Bruno Pigott announced a $194M Water Infrastructure Finance and Innovation Act loan to King County in Washington.
-
Biden-Harris Administration Announces Over $124M For Tennessee Drinking Water, Wastewater And Stormwater Infrastructure Upgrades As Part Of President Biden's Investing In America Agenda2/23/2024
The U.S. Environmental Protection Agency (EPA) announced over $124M from President Biden’s Investing in America agenda for Tennessee drinking water and clean water infrastructure upgrades.
-
EPA Announces $268M WIFIA Loan For Substantial Water Reuse Project In Virginia10/24/2024
Today, the U.S. Environmental Protection Agency announced a $268M Water Infrastructure Finance and Innovation Act (WIFIA) loan to Hampton Roads Sanitation District (HRSD), which serves areas across southeast Virginia and the Eastern Shore.